Overview
Yaohua Chen practices practicing medicine in Lille, France.
Chen is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Dementia, COVID-19, Alzheimer's Disease, and Severe Acute Respiratory Syndrome (SARS).
They are actively involved in clinical research, co-authoring 38 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yaohua S. Chen
Is Yaohua S. Chen a top-rated expert for Dementia?
MediFind is an objective health platform that identifies experts based on real-world data. Yaohua S. Chen is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yaohua S. Chen participate in research or clinical trials?
Yes. Yaohua S. Chen has published 38 articles and abstracts on conditions like Dementia. You can view a list of Yaohua S. Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DementiaChen isAdvanced. Learn about Dementia.
- Experienced
- Alzheimer's DiseaseChen isExperienced. Learn about Alzheimer's Disease.
- COVID-19Chen isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)